APA (7th ed.) Citation

Ravi, H., Arias-Lorza, A. M., Costello, J. R., Han, H. S., Jeong, D. K., Klinz, S. G., . . . Raghunand, N. (2023). Pretherapy Ferumoxytol-enhanced MRI to Predict Response to Liposomal Irinotecan in Metastatic Breast Cancer. Radiology. Imaging cancer, 5(2), e220022. https://doi.org/10.1148/rycan.220022

Chicago Style (17th ed.) Citation

Ravi, Harshan, Andres M. Arias-Lorza, James R. Costello, Hyo Sook Han, Daniel K. Jeong, Stephan G. Klinz, Jasgit C. Sachdev, Ronald L. Korn, and Natarajan Raghunand. "Pretherapy Ferumoxytol-enhanced MRI to Predict Response to Liposomal Irinotecan in Metastatic Breast Cancer." Radiology. Imaging Cancer 5, no. 2 (2023): e220022. https://doi.org/10.1148/rycan.220022.

MLA (9th ed.) Citation

Ravi, Harshan, et al. "Pretherapy Ferumoxytol-enhanced MRI to Predict Response to Liposomal Irinotecan in Metastatic Breast Cancer." Radiology. Imaging Cancer, vol. 5, no. 2, 2023, p. e220022, https://doi.org/10.1148/rycan.220022.